SCHEMBL20677391

SCHEMBL20677391

CCOc1c(Nc2ccc(Cl)c(S(C)(=O)=NC(C)N(C)C)c2O)c(=O)c1=O

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CCR6 P51684 19/20 0.49
▸ GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17871610 0.83 CCR6 (0.47) CCR6GAA
SCHEMBL1706775 0.83 GAA (0.53) CCR6GAA
SCHEMBL1706737 0.82 CCR6 (0.68) CCR6
SCHEMBL17871639 0.80 CXCR2 (0.48) CCR6GAA
SCHEMBL1579382 0.79 CXCR2 (0.61) CCR6
SCHEMBL20721128 0.78 CCR6 (0.64) CCR6
SCHEMBL1579035 0.77 CCR6 (0.53) CCR6
SCHEMBL2296860 0.76 CCR6 (0.53) CCR6
SCHEMBL14895001 0.74 CCR6 (0.65) CCR6GAA
SCHEMBL20721260 0.73 CCR6 (0.69) CCR6GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237384-B1 NOVEL CHEMOKINE CXCR1 AND CXCR2 RECEPTOR ANTAGONIST COMPOUNDS, AND USE THEREOF IN THE TREATMENT OF CHEMOKINE-MEDIATED PATHOLOGIES GALDERMA RES & DEV (FR) 2019-01-30 — — EP claimed
Send feedback